Quince Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Quince Therapeutics, Inc.‘s stocks are currently a part of 22 hedge funds’ portfolios, which represents 5.49% of the total amount of its stocks outstanding. This makes up a total of 1.83M shares of Quince Therapeutics, Inc.. Compared to the previous quarter, the number fell by -65.86% or -3.54M shares fewer. As for the holding position changes, 13.64% (3) of current hedge fund investors increased the number of shares held, 36.36% (8) of current holders sold a part of the shares held, and 22.73% (5) closed the holdings completely. 4 hedge funds are new holders of Quince Therapeutics, Inc. stock in Q1 2023, it is 18.18% of total holders.
Hedge funds holding Quince Therapeutics (Q2 2019 – Q1 2023)
| Q2 2019 | 1 |
|---|---|
| Q3 2019 | 1 |
| Q4 2019 | 3 |
| Q1 2020 | 3 |
| Q2 2020 | 3 |
| Q3 2020 | 2 |
| Q4 2020 | 3 |
| Q1 2021 | 3 |
| Q2 2021 | 3 |
| Q3 2021 | 2 |
| Q4 2021 | 3 |
| Q1 2022 | 2 |
| Q2 2022 | 3 |
| Q3 2022 | 50 |
| Q4 2022 | 43 |
| Q1 2023 | 22 |
Hedge funds changes in Quince Therapeutics positions (Q2 2019 – Q1 2023)
| Q2 2019 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2019 | 0 | 0 | 1 | 0 | 0 |
| Q4 2019 | 2 | 0 | 1 | 0 | 0 |
| Q1 2020 | 0 | 0 | 0 | 0 | 3 |
| Q2 2020 | 0 | 2 | 0 | 0 | 1 |
| Q3 2020 | 0 | 0 | 0 | 0 | 2 |
| Q4 2020 | 0 | 1 | 0 | 0 | 2 |
| Q1 2021 | 0 | 0 | 0 | 0 | 3 |
| Q2 2021 | 0 | 1 | 0 | 0 | 2 |
| Q3 2021 | 0 | 0 | 0 | 0 | 2 |
| Q4 2021 | 0 | 2 | 0 | 0 | 1 |
| Q1 2022 | 0 | 1 | 0 | 2 | -1 |
| Q2 2022 | 0 | 1 | 1 | 0 | 1 |
| Q3 2022 | 6 | 41 | 2 | 0 | 1 |
| Q4 2022 | 9 | 3 | 22 | 16 | -7 |
| Q1 2023 | 4 | 3 | 8 | 5 | 2 |
Hedge funds changes in Quince Therapeutics stock options (Q2 2019 – Q1 2023)
| Q2 2019 | 0 | 0 |
|---|---|---|
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 0 | 0 |
| Q1 2022 | 0 | 0 |
| Q2 2022 | 0 | 0 |
| Q3 2022 | 299,000 | 163,000 |
| Q4 2022 | 196,415 | 15,871 |
| Q1 2023 | 0 | 0 |